Rankings
▼
Calendar
VCYT Q1 2016 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena
VCYT
Veracyte, Inc.
$3B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$14M
Gross Profit
$7M
53.7% margin
Operating Income
-$10M
-72.0% margin
Net Income
-$10M
-74.4% margin
EPS (Diluted)
$-0.36
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$11M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$84M
Total Liabilities
$41M
Stockholders' Equity
$43M
Cash & Equivalents
$47M
← FY 2016
All Quarters
Q2 2016 →